Molecular Biology Program
The Prasad Jallepalli Lab
Research
Professor
Our laboratory is interested in how human cells accurately duplicate and transmit their chromosomes during each round of division.
Featured News
Publications Highlights
J. Maciejowski, H. Dreschler, K. Grundner-Culemann, E.R. Ballister, J.-A. Rodriguez-Rodriguez, V. Rodriguez-Bravo, M.J.K. Jones, E. Foley, M.A. Lampson, H. Daub, A.D. McAinsh, and P.V. Jallepalli. Mps1 regulates kinetochore-microtubule attachment stability via the Ska complex to ensure error-free chromosome segregation. Dev. Cell 41, 153-156 (2017).
V. Rodriguez-Bravo, J. Maciejowski, J. Corona, H.K. Buch, M.T. Kanemaki, J.V. Shah, and P.V. Jallepalli. Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor. Cell 156, 1017-1031 (2014).
People
Prasad Jallepalli, MD, PhD
Member
Professor
- Molecular biologist Prasad Jallepalli studies the mechanisms that ensure accurate chromosome transmission in human cells.
- MD, PhD, Johns Hopkins University School of Medicine
- [email protected]
- Email Address
- 212-639-3252
- Office Phone
Members
- Wesleyan University
Lab Alumni
Lab Affiliations
Achievements
- Phi Beta Kappa, Harvard University (1992)
- M.D./Ph.D. Fellow, Medical Scientist Training Program, Johns Hopkins University (1992-1999)
- Postdoctoral Fellow, Damon Runyon Cancer Foundation (1999-2002)
- Scholar, V Foundation for Cancer Research (2003)
- Frederick R. Adler Chair for Junior Faculty (2003-2007)
Read more
- Pew Scholar in the Biomedical Sciences (2003-2007)
- Louise & Allston Boyer Young Investigator Award (2008)
- Research Scholar, American Cancer Society (2008-2011)
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Career Opportunity
Get in Touch
-
Lab Head Email
-
Office Phone
-
Lab Phone
-
Lab Fax
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Prasad Jallepalli discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].